These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14414254)

  • 1. [Treatment of hemophilia B with a plasma fraction rich in antihemophilic B factor (P.P.B.)].
    LARRIEU MJ; CAEN J; SOULIER JP; BERNARD J
    Pathol Biol; 1959 Dec; 7():2507-13. PubMed ID: 14414254
    [No Abstract]   [Full Text] [Related]  

  • 2. RESULTS with antihemophilic plasma.
    N Y State J Med; 1953 Mar; 53(5):559. PubMed ID: 13037057
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in the blood-clotting defect in Christmas disease after plasma and serum transfusions.
    NOUR-ELDIN F; WILKINSON JF
    Clin Sci; 1958; 17(2):303-308. PubMed ID: 13537347
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hemophilia A with human antihemophilic globulin.
    BLOMBACK M; NILSSON IM
    Acta Med Scand; 1958 Jun; 161(4):301-21. PubMed ID: 13544880
    [No Abstract]   [Full Text] [Related]  

  • 5. [Improvement of indices of the blood coagulation system in patients with hemophilia during physical exercise].
    Damsker IS; Kotovshchikova MA; Fedorova ZD; Kuz'min VA; Abramov VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):24-6. PubMed ID: 5349820
    [No Abstract]   [Full Text] [Related]  

  • 6. [The dosage of antihemophilic globulin, or antihemophilic plasma as well as Cohn's fraction I in factor VIII deficiency].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):363-8. PubMed ID: 4195283
    [No Abstract]   [Full Text] [Related]  

  • 7. The stability of Christmas factor; a guide to the management of Christmas disease.
    BRAFIELD AJ; CASE J
    Lancet; 1956 Oct; 271(6948):867-9. PubMed ID: 13368543
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antihemophilic A fractions].
    SOULIER JP
    Sem Hop Ther Paris; 1961 Jul; 37():612-3. PubMed ID: 13915416
    [No Abstract]   [Full Text] [Related]  

  • 9. The history of hemophilia.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2014 Jul; 40(5):571-6. PubMed ID: 24911674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous plasma in therapy of hemophilia B.
    ATKINSON JB; MILANI FA; HESCH JA; ATKINSON GR
    Pa Med J; 1961 Nov; 64():1459-61. PubMed ID: 13863105
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment for hemophilia: recombinant versus plasma-derived coagulation factors - controversy and debate forever? An ethical medical challenge?
    Liras A; García-Trenchard R
    Expert Rev Hematol; 2013 Oct; 6(5):489-92. PubMed ID: 24083561
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiologic considerations in the management of hemophilia.
    Briggs DK
    Pathobiol Annu; 1971; 1():205-14. PubMed ID: 4950380
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis.
    Escobar M; Sallah S
    J Thromb Haemost; 2013 Aug; 11(8):1449-53. PubMed ID: 23763284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia: in review.
    Zimmerman B; Valentino LA
    Pediatr Rev; 2013 Jul; 34(7):289-94; quiz 295. PubMed ID: 23818083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy for AHF and PTC hemophilia. I.
    Seeler RA
    IMJ Ill Med J; 1970 May; 137(5):518-21. PubMed ID: 4392774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Advances in the field of hemophilia therapy].
    Loeliger EA; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract]   [Full Text] [Related]  

  • 17. [Substitution treatment in hemophilia. Critical measures and complications].
    Schimpf K
    Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemophilia B; two cases of hereditary hemophilia due to a deficiency of a new clotting factor (Christmas factor)].
    CRAMER R; FLUCKIGER P; GASSER C; KOLLER F; LOELIGER A; MATTER M
    Acta Haematol; 1953 Aug; 10(2):64-76. PubMed ID: 13091697
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE BLOOD COAGULATION SYSTEM IN FEMALE CARRIERS OF HEMOPHILIA A AND B].
    LOPACIUK S
    Pol Arch Med Wewn; 1964; 34():165-74. PubMed ID: 14151487
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with hemophilia A and B.
    Hansson KM; Gustafsson D; Skärby T; Frison L; Berntorp E
    J Thromb Haemost; 2015 Jul; 13(7):1293-300. PubMed ID: 25944555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.